A regulatory network for the efficient control of transgene expression

Expression of heterologous genes in mammalian cells or organisms for therapeutic or experimental purposes often requires tight control of transgene expression. Specifically, the following criteria should be met: no background gene activity in the off‐state, high gene expression in the on‐state, regulated expression over an extended period, and multiple switching between on‐ and off‐states.

[1]  E. Mekada,et al.  One molecule of diphtheria toxin fragment a introduced into a cell can kill the cell , 1978, Cell.

[2]  Jun Ma,et al.  GAL4-VP16 is an unusually potent transcriptional activator , 1988, Nature.

[3]  G. Evans.  Dissecting mouse development with toxigenics. , 1989, Genes & development.

[4]  M. Ptashne,et al.  A vector for expressing GAL4(1-147) fusions in mammalian cells. , 1989, Nucleic acids research.

[5]  C. Caskey,et al.  Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. , 1989, Nucleic acids research.

[6]  Philippe Soriano,et al.  Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. , 1991, Genes & development.

[7]  G. Nolan,et al.  Improved FACS-Gal: flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs. , 1991, Cytometry.

[8]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Smale,et al.  Direct recognition of initiator elements by a component of the transcription factor IID complex. , 1994, Genes & development.

[10]  H. Thiesen,et al.  Krüppel-associated boxes are potent transcriptional repression domains. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Ackland-Berglund Ce,et al.  Efficacy of tetracycline-controlled gene expression is influenced by cell type , 1995 .

[12]  U. Deuschle,et al.  Tetracycline-reversible silencing of eukaryotic promoters , 1995, Molecular and cellular biology.

[13]  M. Gossen,et al.  Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.

[14]  B. O’Malley,et al.  The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing , 1995, Molecular and cellular biology.

[15]  The WRPW motif of the hairy-related basic helix-loop-helix repressor proteins acts as a 4-amino-acid transcription repression and protein-protein interaction domain. , 1996, Molecular and cellular biology.

[16]  M. Levine,et al.  Transcriptional repression in development. , 1996, Current opinion in cell biology.

[17]  D A Burns,et al.  Accelerating the pace of luciferase reporter gene assays. , 1996, BioTechniques.

[18]  M. Gossen,et al.  Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. , 1997, Nucleic acids research.

[19]  D. Bohl,et al.  Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts , 1997, Nature Medicine.

[20]  R. Evans,et al.  Inducible gene expression in mammalian cells and transgenic mice. , 1997, Current opinion in biotechnology.

[21]  N. Joshi,et al.  Doxycycline revisited. , 1997, Archives of internal medicine.

[22]  A novel method to isolate cells with conditional gene expression using fluorescence activated cell sorting. , 1997, Nucleic acids research.

[23]  V. Allgood,et al.  Chimeric receptors as gene switches. , 1997, Current opinion in biotechnology.

[24]  H. Blau,et al.  Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16 , 1998, Nature Genetics.

[25]  E. Davidson,et al.  Genomic cis-regulatory logic: experimental and computational analysis of a sea urchin gene. , 1998, Science.

[26]  P Aebischer,et al.  Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts , 1998, Gene Therapy.

[27]  G. Fishman,et al.  Conditional lineage ablation to model human diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  N. Wittenburg,et al.  Tetracycline-inducible expression systems with reduced basal activity in mammalian cells. , 1999, Nucleic acids research.

[29]  Hermann Bujard,et al.  A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells , 1999, The journal of gene medicine.

[30]  H. Blau,et al.  Tet B or not tet B: advances in tetracycline-inducible gene expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Gossen,et al.  Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Russell.  9 – INDUCIBLE MAMMALIAN EXPRESSION SYSTEMS , 1999 .